Jaime Contreras is President & VP at ABBOTT LABORATORIES (ABT). They have made 16 open-market trades across 1 company since 2013, most recently 2020-04-21.
CIK 0001587070
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 16 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ABT | 145,431 | $16.8M |
Shares reported on the most recent Form 4, priced at the 2020-04-23 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ABT | SELL | 2020-03-02 | 2020-03-03 | $77.89 | $312K | +1.2% | -1.5% | +15.3% |
| ABT | SELL | 2019-04-25 | 2019-04-29 | $70.02 | $863K | -2.4% | -3.3% | +13.1% |
| ABT | SELL | 2019-04-25 | 2019-04-29 | $70.00 | $5.8M | -2.4% | -3.3% | +13.1% |
| ABT | SELL | 2019-04-22 | 2019-04-24 | $73.12 | $134K | +3.2% | +0.5% | +15.8% |
| ABT | SELL | 2019-03-01 | 2019-03-04 | $78.28 | $1.0M | +0.5% | +1.2% | -3.6% |
| ABT | SELL | 2019-03-01 | 2019-03-04 | $78.28 | $787K | +0.5% | +1.2% | -3.6% |
| ABT | SELL | 2019-01-30 | 2019-02-01 | $70.00 | $12.4M | +2.7% | +8.6% | +8.8% |
| ABT | SELL | 2018-08-29 | 2018-08-31 | $66.84 | $4.5M | +2.6% | +11.1% | +9.8% |
| ABT | SELL | 2018-08-29 | 2018-08-31 | $66.77 | $7.3M | +2.6% | +11.1% | +9.8% |
| ABT | SELL | 2018-08-29 | 2018-08-31 | $66.74 | $6.4M | +2.6% | +11.1% | +9.8% |
| ABT | SELL | 2018-04-23 | 2018-04-25 | $59.36 | $101K | +1.1% | +6.3% | +9.7% |
| ABT | SELL | 2018-03-01 | 2018-03-02 | $59.57 | $457K | +6.7% | -1.2% | +4.4% |
| ABT | SELL | 2017-09-22 | 2017-09-26 | $51.97 | $2.7M | +4.1% | +5.0% | +7.9% |
| ABT | SELL | 2017-09-22 | 2017-09-26 | $51.98 | $602K | +4.1% | +5.0% | +7.9% |
| ABT | SELL · 10b5-1 | 2017-03-31 | 2017-04-04 | $44.64 | $34K | -1.9% | +1.0% | +10.3% |
| ABT | SELL | 2017-02-28 | 2017-03-02 | $45.02 | $1.2M | -1.4% | -2.1% | +0.5% |
| ABT | SELL · 10b5-1 | 2016-03-31 | 2016-04-01 | $41.78 | $19K | +2.4% | -8.2% | -7.2% |
| ABT | SELL | 2016-02-29 | 2016-03-02 | $38.94 | $823K | +5.0% | +9.4% | +2.8% |
| ABT | SELL · 10b5-1 | 2016-02-16 | 2016-02-17 | $37.87 | $10K | +1.0% | +6.4% | -1.6% |
| ABT | SELL · 10b5-1 | 2015-03-31 | 2015-04-02 | $46.43 | $11K | -8.3% | -2.3% | -2.3% |
| ABT | SELL · 10b5-1 | 2015-03-02 | 2015-03-03 | $47.34 | $436K | -8.3% | -2.3% | -2.3% |
| ABT | SELL · 10b5-1 | 2015-02-18 | 2015-02-18 | $46.26 | $20K | -8.3% | -2.3% | -2.3% |
| ABT | SELL · 10b5-1 | 2014-11-25 | 2014-11-26 | $44.07 | $2.3M | -8.3% | -2.3% | -2.3% |
| ABT | SELL · 10b5-1 | 2014-11-10 | 2014-11-12 | $43.68 | $275K | -8.3% | -2.3% | -2.3% |
| ABT | SELL · 10b5-1 | 2014-03-03 | 2014-03-04 | $39.37 | $318K | -8.3% | -2.3% | -2.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.